Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel targets in Alzheimer’s disease: A special focus on microglia
Claudia Balducci, Gianluigi Forloni
Pharmacological Research (2018) Vol. 130, pp. 402-413
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Stephen D. Skaper, Laura Facci, Morena Zusso, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 387
Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders
Muhammad Ayaz, Abdul Sadiq, Muhammad Junaid, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 291
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 383-383
Open Access | Times Cited: 197
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
The link between chronic pain and Alzheimer’s disease
Song Cao, Daniel Fisher, Tain Yu, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 136
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
Milica Cerovic, Gianluigi Forloni, Claudia Balducci
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 114
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1267-1267
Open Access | Times Cited: 112
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
Giulia Santamaria, Edoardo Brandi, Pietro La Vitola, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 1, pp. 203-218
Open Access | Times Cited: 82
Treadmill Exercise Decreases Aβ Deposition and Counteracts Cognitive Decline in APP/PS1 Mice, Possibly via Hippocampal Microglia Modifications
Xianliang Zhang, Qiang He, Tao Huang, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 81
Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer’s disease
Giuseppa Mudò, Monica Frinchi, Domenico Nuzzo, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 72
The intestinal microbiome and Alzheimer's disease: A review
Zhuo Li, Hua Zhu, Ling Zhang, et al.
Animal Models and Experimental Medicine (2018) Vol. 1, Iss. 3, pp. 180-188
Open Access | Times Cited: 64
Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
Paola Chiozzi, Alba Clara Sarti, Juana María Sanz, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 58
Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer, Atherosclerosis and Cancer
Dana Atrahimovich, Dorit Avni, Soliman Khatib
Antioxidants (2021) Vol. 10, Iss. 3, pp. 423-423
Open Access | Times Cited: 44
GABA‐containing compound gammapyrone protects against brain impairments in Alzheimer’s disease model male rats and prevents mitochondrial dysfunction in cell culture
Vladimirs Piļipenko, Karīna Narbute, Ines Amara, et al.
Journal of Neuroscience Research (2019) Vol. 97, Iss. 6, pp. 708-726
Closed Access | Times Cited: 53
Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
Md. Sahab Uddin, Abdullah Al Mamun, Dewan Md. Sumsuzzman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 34
P38α MAPK Signaling—A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease
Ursula A. Germann, John Alam
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5485-5485
Open Access | Times Cited: 33
SAM Alleviates Neuroinflammation by Regulating M1/M2 Polarization of Microglia Through α7nAChR/Nrf2/HO-1 Signaling Pathway
Kang Ma, Jiandong Niu, Liang Zeng, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
Na Li, Mingru Deng, Gonghui Hu, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1722-1722
Open Access | Times Cited: 18
Polydopamine/Ruthenium Nanoparticle Systems as Photothermal Therapy Reagents and Reactive Oxygen Species Scavengers for Alzheimer’s Disease Treatment
Yanan Liu, Yutong Chen, Youcong Gong, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 7, pp. 5384-5393
Closed Access | Times Cited: 10
Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer’s disease
Rong-Hao Mu, Xiaoying Hou, Qi Liu, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111786-111786
Closed Access | Times Cited: 3
Multidirectional associations between the gut microbiota and Parkinson’s disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway
Xiaokang Jia, Qiliang Chen, Yuanyuan Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
Ju‐Young Lee, Jin Han Nam, Youngpyo Nam, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 26
M 1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
Science Signaling (2022) Vol. 15, Iss. 760
Open Access | Times Cited: 14
Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer’s disease
Hyunkyung Mo, Juryun Kim, Jennifer Yejean Kim, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Disruption of Brain Redox Homeostasis, Microglia Activation and Neuronal Damage Induced by Intracerebroventricular Administration of S-Adenosylmethionine to Developing Rats
Bianca Seminotti, Ângela Zanatta, Rafael Teixeira Ribeiro, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 4, pp. 2760-2773
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top